Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 EuTCV trial in Africa
PACTR202112680671189Phase 3Completed
- Sponsor
- EuBiologics
- Start
- Dec 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 3, randomised trial of Typhoid Vi conjugate vaccine in typhoid fever (3 arms), sponsored by EuBiologics. Started Dec 2021; status: completed.
02
Drugs
Typhoid Vi conjugate vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on PACTR202112680671189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202112680671189.